Journals Endocrinology, Diabetes & Meta...

Endocrinology, Diabetes & Metabolism
Emmanuel K Ofori, Alfred Buabeng, Seth D Amanquah, Kwabena O Danquah, Seth K Amponsah, Wormenor Dziedzorm, Francis K Dogodzi, Laurinda X Adusu-Donkor, Segla K Bernard, Henry Asare-Anane
INTRODUCTION: Insulin resistance (IR) is one of the common chronic metabolic disorders in Africa and elsewhere. Accumulation of lipids in the body may be due to an imbalance in the metabolism of lipids, glucose and proteins. Ceramides are a sphingolipid class of lipids that are biologically active and vital in the production of more complex lipids. Circulating ceramides are thought to have a role in the development of obesity-related IR, although the precise involvement remains unclear...
March 23, 2023: Endocrinology, Diabetes & Metabolism
(no author information available yet)
No abstract text is available yet for this article.
March 20, 2023: Endocrinology, Diabetes & Metabolism
Thoraya Mohamed Ahmed, Mahmoud Nassar, Hanaa Ahmed Abdallah Mohamed, Khaled El-Sayed Elhadidy, Hanan Mohamed Farhan, Ahmed Sayed Abd El Basset, Riem M Elmessiery, Mahmoud Farid Kamel
INTRODUCTION: Insulin resistance and obesity have been associated with irisin, a protein in fat cells. The levels of irisin in patients with type 2 diabetes mellitus (T2DM) were significantly lower than those in non-diabetics. This study aimed to examine the relationship between serum irisin levels and endothelial dysfunction in patients with T2DM. METHODS: There were 90 participants in this study. We matched 65 patients with T2DM with 25 healthy control participants...
March 14, 2023: Endocrinology, Diabetes & Metabolism
Bay Quang Nguyen, Hau Thi Tran, Huong Thi Thu Nguyen, Thanh Xuan Nguyen, Thu Thi Hoai Nguyen, Tam Ngoc Nguyen, Huyen Thi Thanh Vu
INTRODUCTION: Thyroid nodules are common diseases of the endocrine system, with a 5% prevalence rate in the general population. This study aimed to identify prevalence, clinical, cytological and ultrasonographic features of incidental thyroid cancer and its associated factors in Vietnam. METHODS: This cross-sectional descriptive study consisted of 208 patients with incidental thyroid nodules detected by ultrasound at the Endocrinology Department, Bach Mai Hospital, Hanoi, Vietnam between November 2019 and August 2020...
March 10, 2023: Endocrinology, Diabetes & Metabolism
Christy Chao, Sarah B Andrade, Simon Bergford, Peter Calhoun, John B Welsh, Tomas C Walker
INTRODUCTION: Continuous glucose monitoring (CGM) can guide treatment for people with type 1 (T1D) and type 2 diabetes (T2D). The ANSHIN study assessed the impact of non-adjunctive CGM use in adults with diabetes using intensive insulin therapy (IIT). MATERIALS AND METHODS: This single-arm, prospective, interventional study enrolled adults with T1D or T2D who had not used CGM in the prior 6 months. Participants wore blinded CGMs (Dexcom G6) during a 20-day run-in phase, with treatment based on fingerstick glucose values, followed by a 16-week intervention phase and then a randomized 12-week extension phase with treatment based on CGM values...
March 2, 2023: Endocrinology, Diabetes & Metabolism
Amisha Wallia, Matthew O'Brien, Stephanie Hakimian, Raymond Kang, Andrew Cooper, Nicola Lancki, John J Stephen, Cassandra Aikman, David Liss, Emily Parker, Ronald T Ackermann
AIMS: There is limited research using real-world data to evaluate protective cardiovascular effects of glucagon-like peptide-1 (GLP-1) agonists among adults with type 2 diabetes (T2D) early in treatment. MATERIALS AND METHODS: We conducted a retrospective, active comparator cohort study using 2011-2015 administrative claims data to compare cardiovascular disease (CVD) event rates following initiation of exenatide extended-release (E-ER), exenatide immediate-release (E-IR) or liraglutide in T2D adults who previously received no other antidiabetic medication (ADM) except metformin...
February 24, 2023: Endocrinology, Diabetes & Metabolism
Rana Irilouzadian, Siamak Afaghi, Farzad Esmaeili Tarki, Fatemehsadat Rahimi, Nasser Malekpour Alamadari
BACKGROUND: Elevated C-peptide has been suggested as a risk factor for coronary artery disease (CAD). Elevated urinary C-peptide to creatinine ratio (UCPCR) as an alternative measurement is shown to be related to insulin secretion dysfunction; however, data regarding UCPCR predictive value for CAD in diabetes mellitus (DM) are scarce. Therefore, we aimed to assess the UCPCR association with CAD in type 1 DM (T1DM) patients. METHODS: 279 patients previously diagnosed with T1DM included and categorized into two groups of CAD (n = 84) and without-CAD (n = 195)...
February 20, 2023: Endocrinology, Diabetes & Metabolism
Simona Ghetti, Nathan Kuppermann, Arleta Rewers, Sage R Myers, Jeff E Schunk, Michael J Stoner, Aris Garro, Kimberly S Quayle, Kathleen M Brown, Jennifer L Trainor, Leah Tzimenatos, Andrew D DePiero, Julie K McManemy, Lise E Nigrovic, Maria Y Kwok, Cody S Olsen, T Charles Casper, Nicole S Glaser
INTRODUCTION: Young children with type 1 diabetes (T1D) may be at particularly high risk of cognitive decline following diabetic ketoacidosis (DKA). However, studies of cognitive functioning in T1D typically examine school-age children. The goal of this study was to examine whether a single experience of DKA is associated with lower cognitive functioning in young children. We found that recently diagnosed 3- to 5-year-olds who experienced one DKA episode, regardless of its severity, exhibited lower IQ scores than those with no DKA exposure...
February 14, 2023: Endocrinology, Diabetes & Metabolism
Armina Semnani, Faranak Kazerouni, Saeid Kalbasi, Seyedeh Zahra Shahrokhi, Ali Rahimipour
OBJECTIVES: One of the most well-known oral medications for the treatment of T2DM is metformin. Variants have been found in studies to be useful in detecting new genes connected to T2DM aetiology and affecting metformin's mechanism of action. In this research, we aimed to study two variations of the SLC47A1 gene; rs2250486 and rs67238751, in T2DM patients who had been taking metformin for the first 6 months after the diagnosis in the Iranian population for the first time. DESIGN AND METHODS: A total of 200 individuals were recruited for the study...
February 14, 2023: Endocrinology, Diabetes & Metabolism
Darren Mangion, Nikolai P Pace, Melissa M Formosa
INTRODUCTION: Adipose tissue is the source of a broad array of signalling molecules (adipokines), which mediate interorgan communication and regulate metabolic homeostasis. Alterations in adipokine levels have been causally implicated in various metabolic disorders, including changes in bone mass. Osteoporosis is the commonest progressive metabolic bone disease, characterized by elevated risk of fragility fractures as a result of a reduced bone mass and microarchitectural deterioration...
February 9, 2023: Endocrinology, Diabetes & Metabolism
Shahad W Nussrat, Ali H Ad'hiah
INTRODUCTION: It is suggested that cytokines play a key role in the pathogenesis of type 2 diabetes mellitus (T2DM). Therefore, this study explored two recently discovered cytokines, interleukin (IL)-37 (anti-inflammatory) and IL-39 (pro-inflammatory), in T2DM due to limited data in this context. METHODS: Serum IL-37 and IL-39 levels were determined in 106 T2DM patients and 109 controls using enzyme-linked immunosorbent assay kits. RESULTS: Serum levels (median and interquartile range) of IL-37 (79 [47-102] vs...
February 9, 2023: Endocrinology, Diabetes & Metabolism
Shulamit Witkow, Idit F Liberty, Irina Goloub, Malka Kaminsky, Olga Otto, YonesAbu Rabia, Ilana Harman Boehm, Rachel Golan
INTRODUCTION: The purpose of this study was to introduce and test a simple, individualized carbohydrate counting tool designed for persons with Type 1 Diabetes Mellitus (T1DM) in order to determine whether the tool improved A1C levels for participants with age, education or language barriers. METHODS: In a randomized controlled trial, 85 participants were offered six diabetes instructional sessions free of charge over a six-month period. Forty-one received guidance using the regular carbohydrate counting (RCC) method...
February 7, 2023: Endocrinology, Diabetes & Metabolism
Winy Widjaja, Christopher W Rowe, Christopher Oldmeadow, Daron Cope, Elizabeth A Fradgley, Christine Paul, Christine J O'Neill
INTRODUCTION: De-escalated treatment of hemithyroidectomy without radioactive iodine (RAI) is now accepted for patients with low-risk, well-differentiated thyroid cancer (WDTC). The benefit of long-term follow-up care remains controversial. This study aims to describe parameters associated with less than total thyroidectomy, and discharge from specialist follow-up in patients with low-risk WDTC in Australia. METHODS: An online survey was distributed to Australian members of Endocrine Society of Australia, Australian and New Zealand Endocrine Surgeons, and Australian Society of Otolaryngology, Head and Neck Surgery...
February 3, 2023: Endocrinology, Diabetes & Metabolism
Ashok K Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, Prasanna Kumar K M, Ambika G Unnikrishnan, Hemant Thacker, Bipin Sethi, Subhankar Chowdhury, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Shalini K Menon, Vaibhav Salvi, Deepa Chodankar, Saket Thaker, Chirag Trivedi, Subhash K Wangnoo, Abdul H Zargar, Nadeem Rais
INTRODUCTION: There are limited data on the real-world management of diabetes in the Indian population. In this 2-year analysis of the LANDMARC study, the management of type 2 diabetes mellitus (T2DM) and related complications were assessed. METHOD: This multicenter, observational, prospective study included adults aged ≥25 to ≤60 years diagnosed with T2DM (duration ≥2 years at enrollment) and controlled/uncontrolled on ≥2 anti-diabetic agents...
February 1, 2023: Endocrinology, Diabetes & Metabolism
Rosario Le Moli, Pasqualino Malandrino, Marco Russo, Dario Tumino, Tommaso Piticchio, Adriano Naselli, Valentina Rapicavoli, Antonino Belfiore, Francesco Frasca
INTRODUCTION: Therapy for hypothyroid obese patients is still under definition since the thyrotropin-stimulating hormone (TSH) level is a less reliable marker of euthyroidism than nonobese patients. Indeed, TSH levels positively correlate with body mass index (BMI), and this increase may be a compensatory mechanism aimed at increasing energy expenditure in obese people. In contrast, the correlation of BMI with thyroid hormone levels is not completely clear, and conflicting results have been obtained by several studies...
February 1, 2023: Endocrinology, Diabetes & Metabolism
Maud Injeyan, Sabine Baron, Benjamin Lauzier, Benedicte Gaillard-Le Roux, Manon Denis
INTRODUCTION: Hyperglycaemic hyperosmolar state (HHS) is a known complication of type 2 diabetes mellitus; however, carbonated carbohydrate fluid intake may precipitate a more severe presentation of type 1 diabetes mellitus with hyperosmolar state. The management of these patients is not easy and can lead to severe complications such as cerebral venous thrombosis. METHODS: We present the case of a 21-month-old boy admitted for consciousness disorders revealing a hyperglycaemic hyperosmolar state on a new-onset type 1 diabetes and who developed cerebral venous thrombosis...
February 1, 2023: Endocrinology, Diabetes & Metabolism
Mohammad Javad Najafzadeh, Amir Baniasad, Reza Shahabinejad, Mahdieh Mashrooteh, Hamid Najafipour, Mohammad Hossein Gozashti
BACKGROUND: Metabolic syndrome (MetS) is a global public health concern. Chronic inflammation plays a role in MetS; haematological inflammatory parameters can be used as MetS predicting factors. OBJECTIVE: Hereditary and environmental factors play an important role in the development of MetS. This study aimed to determine the relationship between haematological parameters and MetS in the adult population of southeastern Iran, Kerman. METHODS: This cross-sectional study was a sub-analysis of 1033 subjects who participated in the second phase of the Kerman Coronary Artery Disease Risk Factor Study (KERCADRS)...
January 27, 2023: Endocrinology, Diabetes & Metabolism
Oluwasegun P Olujide, Mariama E Olujide, Jo Leonardi-Bee, Kaushik Chattopadhyay
INTRODUCTION: Over the last few decades, India has witnessed an increase in the number of people with type 2 diabetes mellitus (T2DM). Consequently, several clinical practice guidelines (CPGs) have been developed to assist western and traditional Indian medicine practitioners in managing this disease. This systematic review aimed to evaluate and synthesize the content and quality of these CPGs. METHODS: Several databases and sources were searched from inception to May 2022, to identify CPGs for managing adults with T2DM in India...
January 16, 2023: Endocrinology, Diabetes & Metabolism
Rym Ben Othman, Nadia Ben Amor, Faten Mahjoub, Olfa Berriche, Chaima El Ghali, Amel Gamoudi, Henda Jamoussi
INTRODUCTION: The management of obesity is difficult with many failures of lifestyle measures, hence the need to broaden the range of treatments prescribed. The aim of our work was to study the influence of pre and probiotics on weight loss psychological profile and metabolic parameters in obese patients. METHODS: It is a clinical trial involving 45 obese patients, recruited from the Obesity Unit of the National Institute of Nutrition between March and August 2022 divided into three groups: diet only (low-carbohydrate and reduced energy diet), prebiotics (30 g of carob/day) and probiotics (one tablet containing Bifidobacterium longum, Lactobacillus helveticus, Lactococcus lactis, Streptococcus thermophilus/day)...
January 6, 2023: Endocrinology, Diabetes & Metabolism
Negar Dinarvand, Bahman Cheraghian, Zahra Rahimi, Samaneh Salehipour Bavarsad, Amirhooshang Bavarsad, Narges Mohammadtaghvaei
INTRODUCTION: Type 2 diabetes mellitus (T2DM) is among the world's top 10 leading causes of death. Additionally, prediabetes is a major risk factor for diabetes. Identifying diabetes co-occurring disorders can aid in reducing adverse effects and facilitating early detection. In this study, we evaluated dyslipidaemia, metabolic syndrome (MetS), and liver enzyme levels in pre-diabetic and T2DM patients in the Persian cohort compared to a control group. MATERIALS AND METHODS: In this cross-sectional study, 2259 pre-diabetes, 1664 T2DM and 5840 controls (35-70 years) who were selected from the Hoveyzeh cohort centre were examined...
January 3, 2023: Endocrinology, Diabetes & Metabolism
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.